Skip to main content
Deciphera
  • Our Company
    • Who We Are
    • Leadership
  • Focus Areas
    • Overview
    • Oncology
    • Neurology
    • Immunology
  • Pipeline
    • Ongoing Clinical Trials
    • Presentations & Publications
  • Patients & Care Partners
    • Expanded Access
  • Healthcare Professionals (Coming soon!)
  • Our Medicines
  • Join Us
    • Our Culture
    • Open Positions
  • News

04/23/2025

Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read More

04/23/2025

Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting

Read More

© 2026 Deciphera. All Rights Reserved.

  • Privacy Policy
  • Contact Us
  • Terms of Use
linkedin twitter
Back to top